D048868Chemicals & DrugsD12.644.360.024D12.776.157.057D12.776.476.02433690.965751Adaptor Proteins, Signal Transducingplugins:TwitterTwitterprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonBiochemistryWake Forest School of MedicineDonaldBowdenDonald W. Bowden PhD36.09040200000000-80.26700599999999192Bowden, DonaldProfessorAnthonyAtalaAnthony Atala MD36.08943500000000-80.268632000000003Atala, AnthonyProfessorNicholetteAllredNicholette D. Allred PhD36.09040200000000-80.26700599999999706Allred, NicholetteProfessorBarryFreedmanBarry I. Freedman MD36.08959100000000-80.2685990000000078Freedman, BarryProfessor30631060Zhu GF, Xu YW, Li J, Niu HL, Ma WX, Xu J, Zhou PR, Liu X, Ye DL, Liu XR, Yan T, Zhai WK, Xu ZJ, Liu C, Wang L, Wang H, Luo JM, Liu L, Li XQ, Guo S, Jiang HP, Shen P, Lin HK, Yu DH, Ding YQ, Zhang QLNature communicationsZhu GF, Xu YW, Li J, Niu HL, Ma WX, Xu J, Zhou PR, Liu X, Ye DL, Liu XR, Yan T, Zhai WK, Xu ZJ, Liu C, Wang L, Wang H, Luo JM, Liu L, Li XQ, Guo S, Jiang HP, Shen P, Lin HK, Yu DH, Ding YQ, Zhang QL. Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression. Nat Commun. 2019 01 10; 10(1):112.Nat Commun2019-01-10T00:00:002019Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.31155231Zhang W, Wang G, Xu ZG, Tu H, Hu F, Dai J, Chang Y, Chen Y, Lu Y, Zeng H, Cai Z, Han F, Xu C, Jin G, Sun L, Pan BS, Lai SW, Hsu CC, Xu J, Chen ZZ, Li HY, Seth P, Hu J, Zhang X, Li H, Lin HKCellZhang W, Wang G, Xu ZG, Tu H, Hu F, Dai J, Chang Y, Chen Y, Lu Y, Zeng H, Cai Z, Han F, Xu C, Jin G, Sun L, Pan BS, Lai SW, Hsu CC, Xu J, Chen ZZ, Li HY, Seth P, Hu J, Zhang X, Li H, Lin HK. Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS. Cell. 2019 06 27; 178(1):176-189.e15.Cell2019-05-30T00:00:002019Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS.30322886Paudel I, Hernandez SM, Portalatin GM, Chambers TP, Chambers JWThe Biochemical journalPaudel I, Hernandez SM, Portalatin GM, Chambers TP, Chambers JW. Sab concentrations indicate chemotherapeutic susceptibility in ovarian cancer cell lines. Biochem J. 2018 11 15; 475(21):3471-3492.Biochem J2018-11-15T00:00:002018Sab concentrations indicate chemotherapeutic susceptibility in ovarian cancer cell lines.Internal Medicine, Cardiovascular MedicineInternal Medicine, NephrologyUrologyhttp://www.wfirm.orgWFIRMDhanendraTomarydWq65WI0gyDQK7MzBUYdFHxkXkNDhanendra Tomar PhD, MSc3169Tomar, DhanendraAssistant Professor30140897Myers VD, Gerhard GS, McNamara DM, Tomar D, Madesh M, Kaniper S, Ramsey FV, Fisher SG, Ingersoll RG, Kasch-Semenza L, Wang J, Hanley-Yanez K, Lemster B, Schwisow JA, Ambardekar AV, Degann SH, Bristow MR, Sheppard R, Alexis JD, Tilley DG, Kontos CD, McClung JM, Taylor AL, Yancy CW, Khalili K, Seidman JG, Seidman CE, McTiernan CF, Cheung JY, Feldman AMJAMA cardiologyMyers VD, Gerhard GS, McNamara DM, Tomar D, Madesh M, Kaniper S, Ramsey FV, Fisher SG, Ingersoll RG, Kasch-Semenza L, Wang J, Hanley-Yanez K, Lemster B, Schwisow JA, Ambardekar AV, Degann SH, Bristow MR, Sheppard R, Alexis JD, Tilley DG, Kontos CD, McClung JM, Taylor AL, Yancy CW, Khalili K, Seidman JG, Seidman CE, McTiernan CF, Cheung JY, Feldman AM. Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals. JAMA Cardiol. 2018 10 01; 3(10):929-938.JAMA Cardiol2018-10-01T00:00:002018Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals.http://tomarlab.orgTomar Labhttps://school.wakehealth.edu/Faculty/T/Dhanendra-TomarWFSM Faculty ProfileTwitter Tweets Harvard Tweets33622361Kumar B, Ahmad R, Giannico GA, Zent R, Talmon GA, Harris RC, Clark PE, Lokeshwar V, Dhawan P, Singh ABJournal of experimental & clinical cancer research : CRKumar B, Ahmad R, Giannico GA, Zent R, Talmon GA, Harris RC, Clark PE, Lokeshwar V, Dhawan P, Singh AB. Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation. J Exp Clin Cancer Res. 2021 Feb 23; 40(1):77.J Exp Clin Cancer Res2021-02-23T00:00:002021Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation.true1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessor1.314850.013050833research area of0.8114440.054054386subject area for